cyclosporine has been researched along with Dermatomyositis in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 25 (20.16) | 18.2507 |
2000's | 47 (37.90) | 29.6817 |
2010's | 44 (35.48) | 24.3611 |
2020's | 8 (6.45) | 2.80 |
Authors | Studies |
---|---|
Abe, T; Fujii, A; Kawamoto, S; Nagahori, K; Ono, Y; Takeda, T; Ueda, Y; Yoshino, A | 1 |
Li, M; Li, Y; Lian, L; Wang, K; Xu, S | 1 |
Gima, M; Ide, K; Ito, S; Kamei, K; Koinuma, G; Nishi, K; Ogura, M; Tamai, N | 1 |
Hiratoko, K; Inoue, M; Kanamori, T; Mori, M; Morio, T; Mouri, M; Nishino, I; Okiyama, N; Okubo, M; Shimizu, M; Tanaka, E | 1 |
Honda, M; Kondo, M; Kumakura, S; Moriyama, M; Murakawa, Y; Sumita, Y | 1 |
Camprodon-Gómez, M; Fernández-Codina, A; Pope, JE | 1 |
Akizuki, S; Handa, T; Hashimoto, M; Hosono, Y; Mimori, T; Murakami, K; Nakashima, R; Ohmura, K; Shirakashi, M; Tanizawa, K; Tsuji, H; Yoshifuji, H | 1 |
Akamatsu, T; Enomoto, N; Fujisawa, T; Furuhashi, K; Hozumi, H; Imokawa, S; Inui, N; Kaida, Y; Kamiya, Y; Karayama, M; Koshimizu, N; Kusagaya, H; Matsuda, H; Mikamo, M; Mori, K; Nakamura, Y; Satake, Y; Suda, T; Suzuki, Y; Toyoshima, M; Yasui, H; Yokomura, K | 1 |
Aggarwal, R; Bayat, N; Cimaz, R; Constantin, T; Cuttica, RJ; Davidson, JE; de Oliveira, SK; Dressler, F; Erman, B; Feldman, BM; Huber, AM; Lachenbruch, PA; Lindsley, CB; Magalhaes, CS; Magnusson, B; Miller, FW; Pilkington, CA; Pistorio, A; Punaro, M; Ravelli, A; Reed, AM; Rider, LG; Rinaldi, M; Rockette, H; Rouster-Stevens, K; Ruperto, N; Russo, R; van Royen-Kerkhof, A; Vencovsky, J; Villa, L | 1 |
Deguchi, K; Katayama, T; Kishida, M; Nagotani, S; Sano, S; Suganami, Y; Wakabayashi, H; Wakunami, Y; Yamazaki, K | 1 |
Cacheda, AP; Colom, B; González-Moreno, J; Losada-Lopez, I; Oliver, C; Raya-Cruz, M | 1 |
Inkeles, MS; No, D; Wu, JJ | 1 |
Endo, Y; Fujita, Y; Fukui, S; Hara, K; Ichinose, K; Igawa, T; Ishida, M; Iwamoto, N; Kawakami, A; Kawashiri, SY; Koga, T; Kuwana, M; Nakamura, H; Nishino, A; Origuchi, T; Shimizu, T; Sumiyoshi, R; Suzuki, T; Takatani, A; Tamai, M; Tsuji, S; Umeda, M | 1 |
Golsari, A; Keller, S; Yamamura, J | 1 |
Endo, Y; Fujita, Y; Fukui, S; Hosono, Y; Ichinose, K; Igawa, T; Ishida, M; Iwamoto, N; Kawakami, A; Kawashiri, SY; Koga, T; Kuwana, M; Mimori, T; Nakamura, H; Nishino, A; Origuchi, T; Shimizu, T; Sumiyoshi, R; Takatani, A; Tamai, M; Tsuji, S; Umeda, M | 1 |
Geng, H; Jia, E; Jiang, Y; Qiu, X; Wei, J; Xiao, M; Xiao, Y; Xie, J; Zhang, J; Zhang, Y; Zhong, L | 1 |
Cuttica, R; Fischbach, M; Fueri, E; Giancane, G; Lavarello, C; Magnusson, B; Marini, R; Martini, A; Martino, S; Oliveira, SK; Pagnier, A; Pastore, S; Pistorio, A; Ravelli, A; Ruperto, N; Soler, C; Staņēvicha, V; Ten Cate, R; Uziel, Y; Vojinovic, J; Zulian, F | 1 |
Aoki, N; Fujita, K; Kikuchi, E; Okai, T; Shoji, N; Sonoda, Y; Suzuki, A; Torigai, H; Uekubo, K; Yamashita, H | 1 |
Jones, OY; Katz, JD; Rider, LG | 1 |
Hanafusa, T; Hata, K; Ishida, T; Isoda, K; Kimura, Y; Kotani, T; Makino, S; Shoda, T; Takeuchi, T; Yoshida, S | 1 |
Fujii, K; Hirosako, S; Horio, Y; Ichiyasu, H; Kohrogi, H; Kojima, K; Komatsu, T; Masunaga, A; Nakashima, K; Saita, N; Sakamoto, Y; Sakata, S; Tsumura, S | 1 |
Constable, H; Jones, K; Wood, F | 1 |
Amengual, O; Atsumi, T; Kurita, T; Yasuda, S | 1 |
Go, DJ; Kang, EH; Kwon, HM; Lee, EB; Lee, YJ; Park, JK; Song, YW | 1 |
McHugh, NJ; Tansley, SL; Vermaak, E | 1 |
Dankó, K; Farkas, F; Nagy-Vince, M; Szalmás, O | 1 |
Hasegawa, S; Hirano, R; Kaneyasu, H; Ohga, S; Wakabayashi-Takahara, M; Wakiguchi, H | 1 |
Miossec, P | 1 |
Allain-Launay, E; Angioloni, S; Apaz, MT; Avcin, T; Bernard-Medina, AG; Bica, B; Bracaglia, C; Brochard, K; Cespedes-Cruz, A; Cimaz, R; Corona, F; Couillault, G; Cuttica, R; Dolezalova, P; Dressler, F; Ferriani, V; Fischbach, M; Flato, B; Gerloni, V; Herlin, T; Joos, R; Magnusson, B; Martini, A; Meini, A; Oliveira, S; Pilkington, C; Pistorio, A; Quartier, P; Ravelli, A; Ruperto, N; Russo, R; Sterba, G; Tardieu, M; Trachana, M; Vargova, V; Wouters, C; Wulffraat, N; Zulian, F | 1 |
Arita, M; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Misaki, K; Morita, M; Notohara, K; Noyama, M; Tokioka, F | 1 |
Dale, A; Goldacre, B; Milosevic, I | 1 |
Angioloni, S; Martini, A; Pistorio, A; Ravelli, A; Ruperto, N | 1 |
Bader-Meunier, B; Baildam, E; Bellutti Enders, F; Constantin, T; Dolezalova, P; Feldman, BM; Lahdenne, P; Magnusson, B; McCann, LJ; Nistala, K; Ozen, S; Pilkington, C; Ravelli, A; Russo, R; Uziel, Y; van Brussel, M; van der Net, J; van Royen-Kerkhof, A; Vastert, S; Wedderburn, LR; Wulffraat, N | 1 |
Ikeda, SI; Ishii, W; Kishida, D; Matsuda, M; Shimojima, Y | 1 |
Jedlickova, B; Prusa, R; Segethova, J; Tesfaye, H | 1 |
Hong, YK; Kim, HJ; Yoo, WH | 1 |
Kamata, Y; Minota, S; Nagashima, T; Onishi, S | 1 |
Choy, EH; Gordon, P; Hoogendijk, JE; Lecky, B; Winer, JB | 1 |
Ando, M; Ishii, T; Ito, T; Kumamoto, T; Miyazaki, E; Nureki, S; Sadamura, Y; Takenaka, R; Yamasue, M | 1 |
Hanafusa, T; Kotani, T; Makino, S; Nuri, K; Shoda, T; Takeuchi, T | 1 |
Fujiki, Y; Hanafusa, T; Hata, K; Isoda, K; Kotani, T; Makino, S; Nagai, K; Shiba, H; Takeuchi, T; Yoshida, S | 1 |
Asano, Y; Ihn, H; Kadono, T; Kawashima, T; Kubo, M; Sato, S; Sugaya, M; Tada, Y; Tamaki, K; Tamaki, Z; Tomita, M; Yazawa, N | 1 |
Kawashima, T; Kuroda, T; Matsuzawa, Y; Nishide, T; Shirai, K; Wakabayashi, T | 1 |
Asano, Y; Etoh, T; Fujimoto, M; Hirabayashi, M; Hoashi, T; Kaji, K; Kuwana, M; Morimoto, R; Noda, S; Sato, S; Sugaya, M; Takekoshi, T; Tamaki, Z; Yamamoto, M | 1 |
Hanafusa, T; Hata, K; Kotani, T; Makino, S; Nagai, K; Shoda, T; Takeuchi, T; Wakura, D; Yoshida, S | 1 |
Jarvis, JN; Kim, NN; Lio, PA; Morgan, GA; Pachman, LM | 1 |
Honma, N; Ogimi, C; Oh-ishi, T; Tanaka, R | 1 |
Dankó, K; Vincze, M | 1 |
Boracchi, P; Ingegnoli, A; Ingegnoli, F; Lubatti, C; Meroni, PL; Zeni, S | 1 |
Fujita, T; Kuwana, M; Sato, S; Suzuki, Y | 1 |
Goto, H; Ohkuma, K; Sada, M; Saraya, T; Takizawa, H; Tanaka, Y; Tsujimoto, N | 1 |
Baba, S; Gono, T; Hanaoka, M; Katsumata, Y; Kawaguchi, Y; Kuwana, M; Okamoto, Y; Ota, Y; Sato, S; Takagi, K; Yamanaka, H | 1 |
Arinuma, Y; Furukawa, H; Futami, H; Hashimoto, A; Iwata, K; Kinoshita, S; Komiya, A; Matsui, T; Moriya, H; Nakayama, H; Nogi, S; Shimada, K; Takaoka, H; Tamama, S; Tohma, S | 1 |
Abuchar, A; Dehesa, L; Kerdel, FA; Nuno-Gonzalez, A; Vitiello, M | 1 |
Aggarwal, R; Oddis, CV | 1 |
Brito, MJ; Conde, M; Queirós, G; Romeira, AM | 1 |
Kashiwabara, K; Ota, K | 1 |
Andrews, J; Hall, MA | 1 |
Abe, S; Harada, H; Hiraga, Y; Inoue, N; Morikawa, Y; Ohmichi, M; Sasaki-Date, H; Shijubo, N; Takahashi, H | 1 |
Chiang, BL; Lin, YC; Lin, YT; Yang, YH | 1 |
Kawamura, N; Kobayashi, I; Kobayashi, K; Okano, M; Sakiyama, Y; Takahashi, Y; Yamada, M | 1 |
Gejyo, F; Ito, S; Kuroda, T; Morikawa, H; Murakami, S; Nakan, M; Satou, T; Tanabe, Y | 1 |
Iwadate, H; Kanno, T; Kasukawa, R; Nishimaki, T; Sugisaki, K; Takeda, I | 1 |
Aizawa, N; Hada, T; Iida, S; Matsui, K; Nakano, T; Niinaka, M; Tominaga, K | 1 |
Hashimoto, T; Hoshi, K; Ikeda, S; Ishii, W; Kato, T; Matsuda, M; Shimojima, Y; Tanaka, Y | 1 |
Rodriguez, C; Sifontes, S; Sterba, G; Vigilanza, P | 1 |
Ehara, N; Fukushima, K; Hayashi, T; Kitaichi, M; Kohno, S; Mukae, H; Nakayama, S; Okuno, K | 1 |
Mayumi, M; Ohshima, Y; Omata, N; Yamada, A; Yasutomi, M | 1 |
Chida, K; Enomoto, N; Fujisawa, T; Hashimoto, D; Ide, K; Miwa, S; Naito, T; Nakano, H; Suda, T; Suzuki, K; Yokomura, K | 1 |
Homma, S; Kawabat, M; Kono, T; Motoi, N; Sakamoto, S; Yoshimur, K | 1 |
Hanafusa, T; Hirano, S; Kagitani, M; Kawasaki, Y; Kotani, T; Makino, S; Tabushi, Y; Takeuchi, T | 1 |
Choy, EH; Hoogendijk, JE; Lecky, B; Winer, JB | 1 |
De Santis, M; Ferraccioli, GF; Tomietto, P | 1 |
Amano, K; Kameda, H; Nagasawa, H; Ogawa, H; Sekiguchi, N; Takei, H; Takeuchi, T; Tokuhira, M | 1 |
Kaşifoğlu, T; Korkmaz, C; Ozkan, R | 1 |
Ando, M; Fukami, T; Kumamoto, T; Matsuno, O; Miyazaki, E; Muramatsu, T; Nureki, S; Tsuda, T; Ueno, T | 1 |
Genth, E; Hunzelmann, N; Kaufmann, J; Krieg, T | 1 |
Eguchi, K; Ejima, E; Ida, H; Kawakami, A; Nakamura, H; Origuchi, T | 1 |
Arai, S; Katsuoka, K; Kusunoki, M; Mii, S; Niiyama, S | 1 |
Bobrowska-Snarska, D; Brzosko, M; Lukjanowicz, M | 1 |
Hanafusa, T; Hata, A; Kagitani, M; Kotani, T; Makino, S; Shoda, T; Tabushi, Y; Takeuchi, T | 2 |
Asanuma, Y; Kawabata, Y; Koyama, S; Moriguchi, M; Tsuda, T | 1 |
Amital, H; Arnson, Y; Dovrish, Z; Hadari, R | 1 |
Fujimoto, T; Hajiro, T; Horie, M; Kashiwagi, A; Kojyo, N; Sugimoto, T | 1 |
Hirai, K; Kingetsu, I; Kurosaka, D; Yamada, A; Yoshida, K | 1 |
Iorizzo, LJ; Jorizzo, JL | 1 |
Bridges, W; Burwick, F; Saadeh, C | 1 |
Nasonov, EL; Nasonova, VA; Shtutman, VZ | 1 |
Allison, H; Peters, AM | 1 |
Casademont, J; Fernández-Solà, J; Grau, JM; Herrero, C; Urbano-Márquez, A | 1 |
Mehregan, DR; Su, WP | 1 |
Gumpel, JM; Keen, RW | 1 |
Cohen, P; Guillevin, L; Prieur, AM; Zeller, V | 1 |
Gentile, S; Giordana, MT; Roccatello, D; Sacerdote, I | 1 |
Adams, EM; Villalba, L | 1 |
Igarashi, T; Kimura, R; Komuta, K; Maeda, K | 1 |
Chida, K; Hayakawa, H; Imokawa, S; Iwata, M; Ohashi, H; Sato, A; Shirai, M; Todate, A; Toyoshima, M; Yagi, H | 1 |
Fantini, F; Gattinara, M; Gerloni, V; Lomater, C; Mazzotti, J | 1 |
Bernstein, BH; Franke, E; Rawlings, DJ; Reiff, A; Richardson, L; Shaham, B; Szer, IS | 1 |
Igarashi, T; Komuta, K; Kuritani, T; Maeda, K | 1 |
Hiraguri, M; Iwamoto, I; Kawai, M; Kita, Y; Kurasawa, K; Miike, S; Nawata, Y; Saito, Y; Takabayashi, K; Watanabe, N | 1 |
Itoh, T; Matsushita, H; Mitsuoka, S; Uji, M | 1 |
Hara, M; Harigai, M; Kamatani, N; Kashiwazaki, S | 1 |
Hara, M; Harigai, M; Takagi, K | 1 |
Ponsot, G; Prieur, AM; Tabarki, B; Tardieu, M | 1 |
Bartůnková, J; Charvát, F; Jarosová, K; Kafková, J; Machácek, S; Nemcová, D; Studýnková, J; Vencovský, J | 1 |
Eguchi, K; Kawabe, Y; Kawakami, A; Migita, K; Origuchi, T; Tanaka, F; Tominaga, M | 1 |
Oddis, CV | 1 |
Chalmers, A; Esdaile, JM; Qushmaq, KA | 1 |
Kurosaka, D; Ozawa, Y; Tajima, N; Yokoyama, T | 1 |
Fukumura, A; Karasawa, H; Kawabata, H; Kim, CG; Masaki, Y; Ogawa, N; Okada, J; Simoyama, K; Sugai, S; Wano, Y | 1 |
Al-Eid, W; Al-Mayouf, SM; Al-Mofada, S; Bahabri, S | 1 |
Kohsaka, H; Koike, R; Kubota, T; Miyasaka, N; Nishio, J; Nonomura, Y; Tsubata, R | 1 |
Bieber, T; Wenzel, J | 1 |
Kanda, H; Kubo, K; Mimura, T | 1 |
Danieli, G; Danieli, MG; Logullo, F; Malcangi, G; Palmieri, C; Piani, M; Salvi, A | 1 |
Inase, N; Miyake, S; Miyasaka, N; Miyazaki, Y; Ohtani, Y; Sawada, M; Takano, S; Yoshizawa, Y | 1 |
Dubowitz, V; Hamill, G; Heckmatt, J; Saunders, C; Stanhope, R | 1 |
Collins, NA; Coppock, JS; Hollinrake, K; Pugh, MT; Rai, A | 1 |
Correia, O; Delgado, L; Nunes, JP; Polónia, J; Resende, C | 1 |
Ansell, BM | 1 |
Buoncompagni, A; Ciccone, O; Cordone, G; De Langlade, E; Fasce, L; Minetti, C; Scribanis, R | 1 |
Lueck, CJ; Swash, M; Trend, P | 1 |
25 review(s) available for cyclosporine and Dermatomyositis
Article | Year |
---|---|
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
Topics: Autoantibodies; Child, Preschool; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Female; Humans; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Methylprednisolone; Rituximab | 2022 |
Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
Topics: Anti-Inflammatory Agents; Autoantibodies; Cyclosporine; Dermatomyositis; Female; Humans; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged | 2018 |
Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review.
Topics: Antibodies; Asian People; Cyclosporine; Dermatomyositis; Erythema; Female; Humans; Methotrexate; Middle Aged; Prednisolone; Pruritus; Thalidomide; Treatment Outcome; Ubiquitin-Activating Enzymes | 2019 |
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
Topics: Anti-Inflammatory Agents; Autoantibodies; Child; Cyclosporine; Dermatomyositis; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Myositis; Prednisone | 2013 |
The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Prognosis; Retrospective Studies; Tacrolimus | 2015 |
The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Cyclosporine; Dermatomyositis; Evidence-Based Medicine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Leukapheresis; Methotrexate; Plasmapheresis; Polymyositis; Practice Guidelines as Topic; Rituximab; Treatment Outcome | 2015 |
Consensus-based recommendations for the management of juvenile dermatomyositis.
Topics: Cyclosporine; Dermatomyositis; Europe; Evidence-Based Medicine; Exercise Therapy; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Patient Care Team; Practice Guidelines as Topic; Prednisolone; Rituximab; Societies, Medical; Sunscreening Agents | 2017 |
Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature.
Topics: Adult; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Mediastinal Emphysema; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Polymyositis; Randomized Controlled Trials as Topic | 2009 |
[New therapeutic approaches for polymyositis and dermatomyositis].
Topics: Adrenal Cortex Hormones; Algorithms; Antineoplastic Agents; Azathioprine; Biological Therapy; Cell Movement; Cyclophosphamide; Cyclosporine; Dermatomyositis; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Paraneoplastic Syndromes; Physical Therapy Modalities; Polymyositis; T-Lymphocytes; Tacrolimus | 2011 |
Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature.
Topics: Adult; Aged; Antibodies, Antinuclear; Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Middle Aged; Polymyositis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
The use of cyclosporine in dermatology.
Topics: Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatomyositis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Prurigo; Psoriasis; Pyoderma Gangrenosum; Skin Diseases; Sweet Syndrome; Urticaria | 2012 |
Therapeutic advances in myositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunomodulation; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Polymyositis; Randomized Controlled Trials as Topic; Tacrolimus | 2012 |
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Polymyositis; Randomized Controlled Trials as Topic | 2005 |
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; CD28 Antigens; Colitis, Ulcerative; Cyclosporine; Cytokines; Dermatomyositis; Humans; Immune Tolerance; Immunosuppressive Agents; Inflammation; Lupus Erythematosus, Systemic; T-Lymphocytes | 2005 |
[The clinical spectrum of dermatomyositis].
Topics: Adult; Age Factors; Azathioprine; Biopsy; Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Dermatomyositis; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Muscles; Mycophenolic Acid; Paraneoplastic Syndromes; Plasmapheresis; Prognosis; Sex Factors; Time Factors | 2005 |
Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature.
Topics: Adult; Antirheumatic Agents; Cyclosporine; Dermatomyositis; Humans; Male; Mediastinal Emphysema; Subcutaneous Emphysema | 2008 |
The treatment and prognosis of dermatomyositis: an updated review.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Azathioprine; Cyclosporine; Dermatomyositis; Drug Administration Schedule; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prognosis | 2008 |
[Prospects of the use of cyclosporin A in rheumatic diseases].
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclosporine; Dermatomyositis; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Rheumatic Diseases; Sjogren's Syndrome | 1994 |
Progressive multifocal leukoencephalopathy during cyclosporine treatment. A case report.
Topics: Brain; Cell Nucleus; Cyclosporine; Dermatomyositis; Fatal Outcome; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Inclusion Bodies, Viral; Leukoencephalopathy, Progressive Multifocal; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polyomaviridae; Prednisolone; Pyelonephritis; Renal Dialysis | 1996 |
Update on therapy for refractory dermatomyositis and polymyositis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Polymyositis; Tacrolimus | 1996 |
Current approach to the treatment of polymyositis and dermatomyositis.
Topics: Adrenal Cortex Hormones; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Lung Diseases; Polymyositis | 2000 |
Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.
Topics: Adult; Aged; Antirheumatic Agents; Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Treatment Outcome | 2000 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Resistance; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Mycophenolic Acid; Polymyositis; Steroids; Tacrolimus | 2001 |
Juvenile dermatomyositis.
Topics: Adrenal Cortex Hormones; Calcinosis; Child, Preschool; Cyclosporine; Cytokines; Dermatomyositis; Disabled Persons; Humans; Prognosis; Recurrence; Virus Diseases | 1992 |
8 trial(s) available for cyclosporine and Dermatomyositis
Article | Year |
---|---|
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Topics: Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Prednisolone; Prospective Studies; Retrospective Studies; Tacrolimus | 2021 |
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Dermatomyositis; Drug Substitution; Drug Therapy, Combination; Humans; Methotrexate; Prednisone; Single-Blind Method | 2019 |
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
Topics: Adolescent; Analysis of Variance; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Dermatomyositis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Prednisone; Treatment Outcome | 2016 |
Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Topics: Acute Disease; Adult; Aged; Cyclophosphamide; Cyclosporine; Dermatomyositis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Diseases, Interstitial; Male; Middle Aged; Pilot Projects; Prednisolone; Probability; Pulse Therapy, Drug; Respiratory Function Tests; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.
Topics: Aged; Cyclosporine; Dermatomyositis; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Retrospective Studies | 2008 |
Cyclosporine A as first choice therapy for dermatomyositis.
Topics: Adult; Aged; Azathioprine; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prednisone | 1994 |
Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Outcome Assessment, Health Care; Polymyositis | 2000 |
[Therapeutic efficacy of cyclosporin A in four cases of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia].
Topics: Adult; Aged; Cyclosporine; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Oxygen; Partial Pressure; Respiratory Insufficiency; Treatment Outcome | 2000 |
91 other study(ies) available for cyclosporine and Dermatomyositis
Article | Year |
---|---|
Anti-MDA5 Antibody-positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and Cyclosporine.
Topics: Adrenal Cortex Hormones; Autoantibodies; Cyclosporine; Dermatomyositis; Female; Humans; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Middle Aged; Nephrotic Syndrome | 2022 |
Combination therapy of tacrolimus, high doses of glucocorticosteroids, and cyclophosphamide against existing historical treatment for patients in severe conditions of interstitial lung diseases complicated with dermatomyositis: A retrospective analysis.
Topics: Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Retrospective Studies; Tacrolimus | 2022 |
Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: A case report.
Topics: Child, Preschool; Cyclophosphamide; Cyclosporine; Dermatomyositis; Hepatic Veno-Occlusive Disease; Humans; Macrophage Activation Syndrome; Male; Thrombotic Microangiopathies | 2023 |
Three cases of autoimmune-associated haemophagocytic syndrome in dermatomyositis with anti-MDA5 autoantibody.
Topics: Antibodies, Antinuclear; Autoantibodies; Bone Marrow Examination; Cyclophosphamide; Cyclosporine; Dermatomyositis; Female; Ferritins; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Pancytopenia | 2020 |
Giant Calcinosis in Dermatomyositis and Scleroderma Overlap.
Topics: Calcinosis; Cyclosporine; Dermatomyositis; Drainage; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Muscle Weakness; Raynaud Disease; Scleroderma, Systemic; Skin Diseases; Subcutaneous Tissue; Symptom Flare Up; Thoracic Wall; Tomography, X-Ray Computed | 2020 |
Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Autoantibodies; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Interferons; Interleukins; Japan; Lung Diseases, Interstitial; Male; Middle Aged; Plasma Exchange; Receptors, Cell Surface; Tacrolimus | 2020 |
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology Inter
Topics: Adolescent; Alanine Transaminase; Antirheumatic Agents; Aspartate Aminotransferases; Child; Creatine Kinase; Cyclosporine; Dermatomyositis; Europe; Fructose-Bisphosphate Aldolase; Glucocorticoids; Humans; L-Lactate Dehydrogenase; Logistic Models; Methotrexate; Muscle Strength; Outcome Assessment, Health Care; Patient Reported Outcome Measures; Prednisone; Reproducibility of Results; Rheumatology; Rituximab; Societies, Medical; Surveys and Questionnaires; Treatment Outcome; United States | 2017 |
A Case of Dermatomyositis with Severe Myalgia and Muscle Weakness Testing Positive for Anti-melanoma Differentiation-associated Gene 5 Antibody.
Topics: Aged; Antibodies; Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1 | 2017 |
Clinical improvement of a patient with both amyopathic dermatomyositis and psoriasis following treatment with cyclosporine.
Topics: Cyclosporine; Dermatologic Agents; Dermatomyositis; Female; Humans; Middle Aged; Psoriasis; Retreatment | 2017 |
Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.
Topics: Aged; Autoantibodies; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Female; Ferritins; Humans; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Methylprednisolone; Mucin-1; Plasma Exchange; Prednisolone; Prognosis | 2018 |
[Juvenile Dermatomyositis].
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Muscle, Skeletal; Polymyositis | 2018 |
Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Asian People; Autoantibodies; Biomarkers; Cyclophosphamide; Cyclosporine; Dermatomyositis; Female; Ferritins; Humans; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Methylprednisolone; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Successful combination therapy with corticosteroids, biweekly intravenous pulse cyclophosphamide and cyclosporin A for acute interstitial pneumonia in patients with dermatomyositis : report of three cases.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Pulse Therapy, Drug | 2013 |
Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [correcte
Topics: Aged; Biomarkers; Case-Control Studies; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Ferritins; Glucocorticoids; Humans; Kaplan-Meier Estimate; Lung Diseases, Interstitial; Male; Middle Aged; Mucin-1; Oxygen; Prednisolone; Prognosis; Proportional Hazards Models; Pulmonary Alveoli; Retrospective Studies | 2014 |
Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cyclophosphamide; Cyclosporine; Dermatomyositis; Female; Hemoperfusion; Humans; Lung Diseases, Interstitial; Middle Aged; Polymyxin B; Treatment Outcome | 2014 |
The patient with acute muscular weakness.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Creatine Kinase; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Humans; Immunosuppressive Agents; Male; Methotrexate; Muscle Weakness; Prednisolone; Treatment Outcome; Young Adult | 2014 |
Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
Topics: Adult; Cyclosporine; Dermatomyositis; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Retrospective Studies; Survival Rate; Time Factors | 2016 |
[Clinical features of patients with juvenile and adult dermatomyositis].
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Muscle Weakness; Recurrence; Retrospective Studies; Young Adult | 2015 |
Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Child, Preschool; Cyclosporine; Cytokines; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Interleukin-18; Interleukin-6; Lung Diseases, Interstitial; Macrophage Activation Syndrome | 2015 |
Progress in the treatment of juvenile dermatomyositis.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone | 2016 |
Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
Topics: Adrenal Cortex Hormones; Aged; Antibodies; Biomarkers; Cyclophosphamide; Cyclosporine; DEAD-box RNA Helicases; Dermatomyositis; Disease Progression; Female; Humans; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Male; Middle Aged; Prognosis; Respiratory Function Tests; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
The PRINTO juvenile dermatomyositis trial.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone | 2016 |
The PRINTO juvenile dermatomyositis trial - Authors' reply.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone | 2016 |
Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
Topics: Adult; Aged; Calcineurin Inhibitors; Clinical Protocols; Cyclosporine; Dermatomyositis; Drug Monitoring; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Lung Diseases, Interstitial; Male; Middle Aged; Patient Acuity; Polymyositis; Respiratory Function Tests; Treatment Outcome | 2017 |
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Dermatomyositis; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Monitoring, Physiologic; Purpura, Thrombocytopenic, Idiopathic; Transplantation Immunology; Young Adult | 2008 |
Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome?
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Paraneoplastic Syndromes; Prednisolone; Pulse Therapy, Drug; Thyroid Neoplasms; Time Factors; Treatment Outcome; Tumor Burden | 2009 |
Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine.
Topics: Adrenal Cortex Hormones; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Tacrolimus; Treatment Failure | 2010 |
[Effective treatment of interstitial pneumonia with tacrolimus in a patient with dermatomyositis who was intolerant to cyclosporin-A].
Topics: Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Middle Aged; Tacrolimus | 2010 |
Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis.
Topics: Aged; Antirheumatic Agents; Area Under Curve; Cyclosporine; Dermatomyositis; Drug Monitoring; Drug Therapy, Combination; Emulsions; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Prednisone | 2011 |
Serum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease.
Topics: Adult; Aged; Chemokine CCL17; Cyclosporine; Dermatomyositis; Female; Humans; L-Lactate Dehydrogenase; Lung Diseases, Interstitial; Male; Middle Aged; Mucin-1; Prednisolone; Pulmonary Surfactant-Associated Protein D; Up-Regulation | 2010 |
Lecithinized superoxide dismutase treatment improves steroid-refractory interstitial pneumonia.
Topics: Adrenal Cortex Hormones; Cyclosporine; Dermatomyositis; Exercise Tolerance; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Mucin-1; Phosphatidylcholines; Prednisolone; Pulmonary Fibrosis; Radiography; Respiratory Function Tests; Superoxide Dismutase; Tacrolimus; Treatment Outcome | 2010 |
Dermatomyositis with anti-OJ antibody.
Topics: Autoantibodies; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Isoleucine-tRNA Ligase; Lung Diseases, Interstitial; Middle Aged; Prednisone; Treatment Outcome | 2011 |
Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia.
Topics: Acute Disease; Adult; Aged; Cyclosporine; Dermatomyositis; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Respiratory Function Tests; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Dermatomyositis; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Methylprednisolone; Mycophenolic Acid; Phototherapy; Prednisone; Psoriasis; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
Topics: Child; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Mycophenolic Acid; Pulse Therapy, Drug; Purpura, Thrombocytopenic; Treatment Failure | 2012 |
Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies.
Topics: Autoantibodies; Cyclosporine; Dermatologic Agents; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intercellular Signaling Peptides and Proteins; Lung Diseases, Interstitial; Middle Aged; Peptides; Prednisolone; Treatment Outcome | 2012 |
Massive tension pneumomediastinum.
Topics: Adult; Bronchiectasis; Cough; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Female; Fever; Humans; Immunosuppressive Agents; Mediastinal Emphysema; Prednisolone; Subcutaneous Emphysema; Tomography, X-Ray Computed | 2012 |
Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis.
Topics: Autoantibodies; Calcineurin Inhibitors; Cyclosporine; DEAD-box RNA Helicases; Dermatomyositis; Drug Therapy, Combination; Female; Ferritins; Glucocorticoids; Humans; Interferon-Induced Helicase, IFIH1; Interleukin-18; Japan; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2012 |
[Case of immunosuppressant-resistant amyopathic dermatomyositis with rapidly progressive interstitial pneumonia ameliorated after resection of gastric cancer].
Topics: Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Drug Resistance; Drug Therapy, Combination; Female; Gastrectomy; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Stomach Neoplasms; Treatment Outcome | 2012 |
Cyclosporine-induced haemolytic anaemia in a child with juvenile dermatomyositis.
Topics: Anemia, Hemolytic; Azathioprine; Child; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Prednisolone; Pulse Therapy, Drug | 2012 |
Rapidly progressive interstitial lung disease in a dermatomyositis patient with high levels of creatine phosphokinase, severe muscle symptoms and positive anti-Jo-1 antibody.
Topics: Anti-Inflammatory Agents; Autoantibodies; Creatine Kinase; Cyclosporine; Dermatomyositis; Disease Progression; Female; Histidine-tRNA Ligase; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Middle Aged; Muscular Diseases; Prognosis; Steroids; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
Dermatomyositis-scleroderma overlap syndrome presenting as autoimmune haemolytic anaemia.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Cyclosporine; Dermatomyositis; Diagnosis, Differential; England; Female; Humans; Immunosuppressive Agents; Prednisolone; Scleroderma, Localized; Syndrome; White People | 2002 |
[A case of nonspecific interstitial pneumonia associated with amyopathic dermatomyositis efficiently treated with a combination of cyclosporin A and prednisolone].
Topics: Adult; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Humans; Lung Diseases, Interstitial; Male; Prednisolone; Treatment Outcome | 2002 |
Steroid refractory interstitial pneumonitis in a patient with juvenile dermatomyositis.
Topics: Anti-Inflammatory Agents; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Humans; Lung Diseases, Interstitial; Methylprednisolone; Pulse Therapy, Drug; Radiography; Treatment Failure | 2002 |
Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cryptogenic Organizing Pneumonia; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Prednisolone; Prognosis; Vital Capacity | 2003 |
A case of dermatomyositis complicated with pneumomediastinum successfully treated with cyclosporin A.
Topics: Administration, Oral; Anti-Inflammatory Agents; Antigens; Antigens, Neoplasm; Cyclosporine; Dermatomyositis; Dose-Response Relationship, Drug; Drug Administration Schedule; Glycoproteins; Humans; Lung Diseases, Interstitial; Male; Mediastinal Emphysema; Middle Aged; Mucin-1; Mucins; Prednisolone; Radiography, Thoracic; Tomography, X-Ray Computed | 2003 |
Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine/cyclophosphamide in two patients with amyopathic dermatomyositis.
Topics: Adrenal Cortex Hormones; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged | 2002 |
[Interstial pneumonia, which activity was reflected on KL-6, associated with dermatomyositis successfully treated with cyclosporin A].
Topics: Anti-Inflammatory Agents; Antigens; Antigens, Neoplasm; Biomarkers; Cyclosporine; Dermatologic Agents; Dermatomyositis; Drug Resistance; Female; Glycoproteins; Humans; Lung Diseases, Interstitial; Middle Aged; Mucin-1; Mucins; Prednisolone; Pulse Therapy, Drug | 2003 |
Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A.
Topics: Adult; Cyclosporine; Dermatomyositis; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Necrosis; Skin | 2003 |
Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis.
Topics: Child; Cyclosporine; Dermatomyositis; Glucocorticoids; Humans; Immunosuppressive Agents; Macrophage Activation; Macrophages; Male; Methotrexate; Syndrome; Treatment Outcome; Withholding Treatment | 2004 |
[A case of amyopathic dermatomyositis with interstitial pneumonia: successful treatment with a combination of prednisolone and cyclosporin A].
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Lung Diseases, Interstitial; Middle Aged; Prednisolone; Pulmonary Alveoli | 2004 |
Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A.
Topics: Adolescent; Biological Availability; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Prednisolone; Tacrolimus | 2004 |
[Cyclosporin treatment of interstitial pneumonia and monitoring of serum concentration].
Topics: Aged; Area Under Curve; Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Pulmonary Fibrosis | 2004 |
[A case of corticosteroid-resistant nonspecific interstitial pneumonia associated with dermatomyositis successfully treated with cyclosporin A].
Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Prednisolone | 2005 |
[A case of interstitial pneumonia associated with dermatomyositis effectively treated with cyclosporin-A and cyclophosphamide pulse].
Topics: Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone | 2005 |
Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis.
Topics: Adult; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Interstitial; Opportunistic Infections; Pneumonia, Viral; Prednisolone; Radiography, Thoracic; Treatment Outcome | 2006 |
Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis.
Topics: Adult; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunization, Passive; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Mediastinal Emphysema; Prognosis; Tomography, X-Ray Computed | 2007 |
Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis.
Topics: Anti-Inflammatory Agents; Calcinosis; Child; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Knee Joint; Male; Prednisolone; Probenecid; Radiography; Range of Motion, Articular; Treatment Outcome; Uricosuric Agents | 2006 |
Cyclosporine A as treatment of esophageal involvement in dermatomyositis.
Topics: Adrenal Cortex Hormones; Aged; Cyclosporine; Deglutition Disorders; Dermatomyositis; Drug Resistance; Humans; Immunosuppressive Agents; Male | 2006 |
[Coexistence of hypothyroidism with polymyositis or dermatomyositis].
Topics: Adult; Cyclophosphamide; Cyclosporine; Dermatomyositis; Female; Humans; Hypothyroidism; Male; Methotrexate; Middle Aged; Muscle Weakness; Polymyositis; Thyroid Hormones | 2006 |
[A patient with interstitial pneumonia associated with dermatomyositis who relapsed after reducing cyclosporin-A treatment].
Topics: Aged; Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Recurrence | 2007 |
A case of hypomyopathic dermatomyositis associated with rapid progressive interstitial pneumonia resistant to multi-immunosuppressive therapy.
Topics: Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Female; gamma-Globulins; Humans; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Middle Aged; Prednisolone; Radiography, Thoracic | 2007 |
Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.
Topics: Adult; Arthralgia; Cyclosporine; Dermatologic Agents; Dermatomyositis; Exanthema; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Prednisone | 2007 |
Thrombotic microangiopathy in an adult patient with clinically amyopathic dermatomyositis complicated with interstitial lung disease.
Topics: Anemia, Hemolytic; Antirheumatic Agents; Cyclosporine; Dermatomyositis; Female; Humans; Lung Diseases, Interstitial; Middle Aged; Prednisolone; Thrombocytopenia; Thrombosis; Vasculitis | 2007 |
Dermatomyositis: remission induced with combined oral cyclosporine and high-dose intravenous immune globulin.
Topics: Administration, Oral; Adult; Child; Combined Modality Therapy; Creatine Kinase; Cyclosporine; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Muscle Contraction; Muscle, Skeletal; Remission Induction | 1995 |
Measurement of the ratio of glomerular filtration rate to plasma volume from the technetium-99m diethylene triamine pentaacetic acid renogram: comparison with glomerular filtration rate in relation to extracellular fluid volume.
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Dermatomyositis; Extracellular Space; Glomerular Filtration Rate; Humans; Kidney Diseases; Middle Aged; Plasma Volume; Radioisotope Renography; Retrospective Studies; Technetium Tc 99m Pentetate | 1994 |
Cyclosporine treatment for dermatomyositis/polymyositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Female; Humans; Hydroxychloroquine; Middle Aged; Polymyositis; Prednisone; Quinacrine | 1993 |
Cyclosporin A in adult dermatomyositis.
Topics: Adult; Cyclosporine; Dermatomyositis; Female; Humans | 1993 |
Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases.
Topics: Biomarkers; Child; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Retrospective Studies | 1996 |
Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
Topics: Adult; Cyclosporine; Dermatomyositis; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Polymyositis | 1997 |
[Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis].
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Treatment Outcome | 1997 |
Cyclosporin in pediatric rheumatology; a seven years experience.
Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Creatine; Cyclosporine; Dermatomyositis; Female; Humans; Infant; Iridocyclitis; Male; Panniculitis; Rheumatic Diseases; Thrombocytopenia | 1994 |
Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.
Topics: Adolescent; Age of Onset; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone; Retrospective Studies | 1997 |
Cyclosporine treatment for interstitial pneumonitis associated with dermatomyositis/polymyositis.
Topics: Cyclosporine; Dermatomyositis; Humans; Lung Diseases, Interstitial; Polymyositis | 1998 |
Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Topics: Adult; Autoimmune Diseases; Cyclosporine; Dermatomyositis; Drug Resistance; Female; Glucocorticoids; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Polymyositis; Prednisolone; Survival Rate | 1999 |
[Successful combination chemotherapy with low-dose methotrexate and steroids for dermatomyositis complicated by interstitial pneumonitis].
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Prednisolone; Pulse Therapy, Drug; Treatment Outcome | 1999 |
[Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
Topics: Anti-Inflammatory Agents; Collagen Diseases; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Polymyositis; Prednisolone; Prospective Studies; Surveys and Questionnaires; Treatment Outcome | 1999 |
[Treatment of interstitial pneumonia associated with polymyositis/dermatomyositis with cyclosporin A].
Topics: Cyclosporine; Dermatomyositis; Drug Resistance, Multiple; Humans; Lung Diseases, Interstitial; Polymyositis; Steroids; Treatment Outcome | 1999 |
Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Creatine Kinase; Cyclosporine; Dermatomyositis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Male; Retrospective Studies; Treatment Outcome | 1998 |
Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis.
Topics: Acute Disease; Adult; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lung Diseases, Interstitial; Prednisolone | 2000 |
[A case of Sjögren's syndrome with dermatomyositis who died of rapidly progressive interstitial pneumonia].
Topics: Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Sjogren's Syndrome | 2001 |
Interstitial pneumonitis and air leakage in juvenile dermatomyositis.
Topics: Child, Preschool; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Lung Diseases, Interstitial; Pneumothorax; Prednisone; Tomography, X-Ray Computed | 2001 |
[A case of dermatomyositis complicated with pneumomediastinum that was successfully treated with cyclosporin A].
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Male; Mediastinal Emphysema; Prednisolone; Treatment Outcome | 2001 |
Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis.
Topics: Adult; Aged; Arthritis, Psoriatic; Behcet Syndrome; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Muscular Diseases; Polymyositis; Risk Assessment | 2001 |
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Plasmapheresis; Polymyositis; Prednisone; Statistics, Nonparametric; Treatment Outcome | 2002 |
Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis.
Topics: Adult; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Prednisolone; Retrospective Studies; Treatment Outcome | 2002 |
"Catch-up" growth in steroid dependent dermatomyositis treated with cyclosporin-A.
Topics: Body Height; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Growth Disorders; Humans; Male; Prednisolone; Time Factors | 1992 |
A case of adult dermatomyositis treated with cyclosporin A.
Topics: Adult; Cyclosporine; Dermatomyositis; Female; Humans | 1992 |
Severe acute form of adult dermatomyositis treated with cyclosporine.
Topics: Acute Disease; Cyclosporine; Dermatomyositis; Drug Resistance; Female; Humans; Middle Aged; Prednisolone; Severity of Illness Index | 1992 |
[Infantile dermatomyositis. Clinical aspects and prospective treatments].
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Biopsy; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Male | 1991 |
Cyclosporin in the management of polymyositis and dermatomyositis.
Topics: Adult; Cyclosporine; Dermatomyositis; Female; Humans; Middle Aged; Myositis | 1991 |